1. Standard Outcome Measures for Thymic Malignancies
James Huang, MD, Frank C. Detterbeck, MD, Zuoheng Wang, PhD, Patrick J. Loehrer, MD 
Journal of Thoracic Oncology 
Volume 5, Issue 12, Pages (December 2010)
DOI: /JTO.0b013e3181f13682
Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Overall cause (A) and stage-specific (B) cause of death after resection of patients with thymoma. Results are an average of studies from 1980 to 2009 of ≥100 patients reporting this data.3
Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181f13682)
Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

3. FIGURE 2
Specific outcomes for a stage III resected thymoma at 10 years, estimated from data regarding overall survival, cause of death, incidence of recurrence, and incidence of other cancers.3
Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181f13682)
Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

4. FIGURE 3
Variance in actuarial survival estimates by size of cohort for (A) a 10-year study duration and (B) a 5-year study duration. The vertical bars are 95% confidence intervals for the survival estimate at 5 and 10 years, based on a standard model of exponentially decreasing survival, a constant rate of accrual of patients during the course of the study until study termination, and no loss to follow-up. MST, median survival time.
Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181f13682)
Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions